View in EDS HTML Full Text PDF Full Text

Stopping nucleot(s)ide analogues in non‐cirrhotic HBeAg‐negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels.

Saved in:
Bibliographic Details
Title: Stopping nucleot(s)ide analogues in non‐cirrhotic HBeAg‐negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels.
Authors: Hall, Samuel A. L.1,2 (AUTHOR) sammy.hall86@gmail.com, Burns, Gareth S.1,2 (AUTHOR), Anagnostou, Despina1 (AUTHOR), Vogrin, Sara2 (AUTHOR), Sundararajan, Vijaya2,3 (AUTHOR), Ratnam, Dilip4,5 (AUTHOR), Levy, Miriam T.6 (AUTHOR), Lubel, John S.7,8 (AUTHOR), Nicoll, Amanda J.9 (AUTHOR), Strasser, Simone I.10,11 (AUTHOR), Sievert, William4,5 (AUTHOR), Desmond, Paul V.1 (AUTHOR), Ngu, Meng C.12 (AUTHOR), Angus, Peter13,14 (AUTHOR), Sinclair, Marie13 (AUTHOR), Meredith, Christopher15 (AUTHOR), Matthews, Gail16 (AUTHOR), Revill, Peter A.17 (AUTHOR), Jackson, Kathy17 (AUTHOR), Littlejohn, Margaret17 (AUTHOR)
Source: Alimentary Pharmacology & Therapeutics. Jul2022, Vol. 56 Issue 2, p310-320. 11p. 2 Charts, 3 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:02692813
DOI:10.1111/apt.16968